GKT137831

setanaxib · Calliditas Therapeutics AB

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GKT137831, covering 2022-03-31 to 2022-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess Safety & Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodiol. [Phase 2]

See pricing